mycetoma, eumycetoma, Madurella mycetomatis, randomised controlled trial, phase II, fosravuconazole, ravuconazole, itraconazole, Sudan
imidazo[1, 2-b]pyridazine, antifungal agents, Madurella mycetomatis, eumycetoma, novel therapeutics, Drug discovery, mycetoma, neglected tropical disease